Reena S. Cecchini

4.9k total citations · 1 hit paper
49 papers, 2.9k citations indexed

About

Reena S. Cecchini is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Reena S. Cecchini has authored 49 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 27 papers in Cancer Research and 19 papers in Genetics. Recurrent topics in Reena S. Cecchini's work include Breast Cancer Treatment Studies (25 papers), Estrogen and related hormone effects (14 papers) and Cancer Risks and Factors (10 papers). Reena S. Cecchini is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Estrogen and related hormone effects (14 papers) and Cancer Risks and Factors (10 papers). Reena S. Cecchini collaborates with scholars based in United States, Canada and Brazil. Reena S. Cecchini's co-authors include Norman Wolmark, Joseph P. Costantino, Walter M. Cronin, D. Lawrence Wickerham, James N. Atkins, André Robidoux, Richard G. Margolese, Leslie G. Ford, Carolyn D. Runowicz and Patricia A. Ganz and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Reena S. Cecchini

44 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

2005 937 citations Bernard Fisher, Joseph P. Costantino et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reena S. Cecchini United States	20	1.8k	1.1k	959	422	393	49	2.9k
Christine D. Berg United States	18	1.2k 0.7×	727 0.7×	768 0.8×	390 0.9×	422 1.1×	43	2.5k
Deborah Collyar United States	22	1.7k 1.0×	682 0.6×	1.7k 1.8×	530 1.3×	477 1.2×	69	3.2k
Laura Cortesi Italy	28	1.0k 0.6×	885 0.8×	712 0.7×	343 0.8×	753 1.9×	172	2.9k
Simon Cawthorn United Kingdom	23	1.7k 1.0×	1.5k 1.4×	1.3k 1.4×	495 1.2×	305 0.8×	54	3.6k
M. Bontenbal Netherlands	31	2.1k 1.2×	667 0.6×	1.2k 1.2×	480 1.1×	575 1.5×	66	3.4k
Moïse Namer France	25	1.8k 1.0×	496 0.5×	1.1k 1.1×	419 1.0×	437 1.1×	62	2.8k
Manuela Rabaglio Switzerland	22	1.2k 0.7×	779 0.7×	819 0.9×	589 1.4×	298 0.8×	83	2.0k
J Cuzick United Kingdom	7	2.0k 1.1×	1.6k 1.6×	2.0k 2.1×	561 1.3×	565 1.4×	10	3.6k
JF Forbes Australia	12	1.7k 0.9×	1.9k 1.8×	1.4k 1.4×	471 1.1×	343 0.9×	26	3.0k
A. De Matteis Italy	21	1.2k 0.7×	533 0.5×	809 0.8×	356 0.8×	317 0.8×	58	2.1k

Countries citing papers authored by Reena S. Cecchini

Since Specialization

Citations

This map shows the geographic impact of Reena S. Cecchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena S. Cecchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena S. Cecchini more than expected).

Fields of papers citing papers by Reena S. Cecchini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reena S. Cecchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena S. Cecchini. The network helps show where Reena S. Cecchini may publish in the future.

Co-authorship network of co-authors of Reena S. Cecchini

This figure shows the co-authorship network connecting the top 25 collaborators of Reena S. Cecchini. A scholar is included among the top collaborators of Reena S. Cecchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reena S. Cecchini. Reena S. Cecchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bandos, Hanna, Pedro A. Torres‐Saavedra, Eva Culakova, et al.. (2025). Best practices and pragmatic approaches for patient-reported outcomes and quality of life measures in cancer clinical trials. JNCI Monographs. 2025(68). 14–21. 3 indexed citations

Gresham, Gillian, N. Lynn Henry, Hanna Bandos, et al.. (2025). Analyses of adverse events and patient‐reported outcomes with the toxicity index in cancer clinical trials. Cancer. 131(S2). e70086–e70086.

Swain, Sandra M., Shannon L. Puhalla, Patricia A. Ganz, et al.. (2024). A phase III trial evaluating addition of adjuvant chemotherapy to ovarian function suppression + endocrine therapy in premenopausal women with pN0-1, HR+/HER2- breast cancer (BC) and oncotype recurrence score (RS) ≤25 (OFSET): NRG-BR009.. Journal of Clinical Oncology. 42(16_suppl). TPS612–TPS612. 3 indexed citations

Calsavara, Vinícius F., N. Lynn Henry, Ron D. Hays, et al.. (2023). Dynamic Risk Prediction of Treatment Discontinuation Using Patient-Reported Outcomes Data in the Phase III NSABP B-35 Trial. Cancer Prevention Research. 16(11). 631–639. 3 indexed citations

Henry, N. Lynn, Sungjin Kim, Ron D. Hays, et al.. (2022). Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30. npj Breast Cancer. 8(1). 123–123. 6 indexed citations

Henry, N. Lynn, Sungjin Kim, Ron D. Hays, et al.. (2021). Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35. Journal of Clinical Oncology. 39(34). 3800–3812. 14 indexed citations

Ganz, Patricia A., Reena S. Cecchini, Louis Fehrenbacher, et al.. (2021). NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab. npj Breast Cancer. 7(1). 55–55. 9 indexed citations

Ruddy, Kathryn J., Daniel J. Schaid, Anthony Batzler, et al.. (2020). Antimullerian Hormone as a Serum Biomarker for Risk of Chemotherapy-Induced Amenorrhea. JNCI Journal of the National Cancer Institute. 113(8). 1105–1108. 5 indexed citations

White, Julia, Kathryn Winter, Reena S. Cecchini, et al.. (2019). Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial. International Journal of Radiation Oncology*Biology*Physics. 105(1). S3–S4. 29 indexed citations

10.

Fehrenbacher, Louis, Reena S. Cecchini, Charles E. Geyer, et al.. (2019). NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+. Journal of Clinical Oncology. 38(5). 444–453. 279 indexed citations

11.

Cecchini, Reena S., Sandra M. Swain, Joseph P. Costantino, et al.. (2015). Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38. Cancer Epidemiology Biomarkers & Prevention. 25(1). 51–59. 33 indexed citations

12.

Ganz, Patricia A., Reena S. Cecchini, Thomas B. Julian, et al.. (2015). Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. The Lancet. 387(10021). 857–865. 59 indexed citations

13.

Margolese, Richard G., Reena S. Cecchini, Thomas B. Julian, et al.. (2015). Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial. The Lancet. 387(10021). 849–856. 127 indexed citations

14.

Cecchini, Reena S., Joseph P. Costantino, Jane A. Cauley, et al.. (2012). Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-Risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials. Cancer Prevention Research. 5(4). 583–592. 92 indexed citations

15.

Runowicz, Carolyn D., Joseph P. Costantino, D. Lawrence Wickerham, et al.. (2011). Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR). American Journal of Obstetrics and Gynecology. 205(6). 535.e1–535.e5. 37 indexed citations

16.

Sucato, Gina S., Stephanie R. Land, Pamela J. Murray, Reena S. Cecchini, & Melanie A. Gold. (2011). Adolescents’ Experiences Using the Contraceptive Patch versus Pills. Journal of Pediatric and Adolescent Gynecology. 24(4). 197–203. 19 indexed citations

17.

Vogel, Victor G., Joseph P. Costantino, D. Lawrence Wickerham, et al.. (2010). Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer. Cancer Prevention Research. 3(6). 696–706. 438 indexed citations

18.

Wickerham, D. Lawrence, Joseph P. Costantino, Victor G. Vogel, et al.. (2008). The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer. Recent results in cancer research. 181. 113–119. 29 indexed citations

19.

Swain, Sandra M., Stephanie R. Land, Joseph P. Costantino, et al.. (2008). Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Research and Treatment. 113(2). 315–320. 77 indexed citations

20.

Fisher, Bernard, Joseph P. Costantino, D. Lawrence Wickerham, et al.. (2005). Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI Journal of the National Cancer Institute. 97(22). 1652–1662. 937 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact